CL2013002712A1 - Immunogenic composition for modulating immune system comprising agents with patterns associated with bacteria, viruses, fungi and yeasts, protozoa, helminths and / or prions; use to treat autoimmune or infectious diseases. - Google Patents

Immunogenic composition for modulating immune system comprising agents with patterns associated with bacteria, viruses, fungi and yeasts, protozoa, helminths and / or prions; use to treat autoimmune or infectious diseases.

Info

Publication number: CL2013002712A1
Authority: CL; Chile
Prior art keywords: helminths; prions; protozoa; yeasts; fungi
Prior art date: 2011-03-18

Application number

CL2013002712A

Other languages

Spanish (es)

Inventor

Alexandre Eduardo Nowill

Original Assignee

Alexandre Eduardo Nowill

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-03-18

Filing date

2013-09-23

Publication date

2014-08-18

2013-09-23 Application filed by Alexandre Eduardo Nowill filed Critical Alexandre Eduardo Nowill

2014-08-18 Publication of CL2013002712A1 publication Critical patent/CL2013002712A1/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/104—Pseudomonadales, e.g. Pseudomonas
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/165—Mumps or measles virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/04—Amoebicides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
- A61K2039/55533—IL-2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Mycology (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Oncology (AREA)
Tropical Medicine & Parasitology (AREA)
Endocrinology (AREA)
Dermatology (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Hematology (AREA)
Molecular Biology (AREA)
Pain & Pain Management (AREA)
Neurosurgery (AREA)
Obesity (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
AIDS & HIV (AREA)
Biomedical Technology (AREA)

CL2013002712A 2011-03-18 2013-09-23 Immunogenic composition for modulating immune system comprising agents with patterns associated with bacteria, viruses, fungi and yeasts, protozoa, helminths and / or prions; use to treat autoimmune or infectious diseases. CL2013002712A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
BRPI1100857-1A BRPI1100857A2 (en)	2011-03-18	2011-03-18	immunomodulatory agent and combinations thereof, their use and immunotherapeutic method for real time recontextualization, reprogramming and rebuilding of the immune system

Publications (1)

Publication Number	Publication Date
CL2013002712A1 true CL2013002712A1 (en)	2014-08-18

Family

ID=46829971

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CL2013002712A CL2013002712A1 (en)	2011-03-18	2013-09-23	Immunogenic composition for modulating immune system comprising agents with patterns associated with bacteria, viruses, fungi and yeasts, protozoa, helminths and / or prions; use to treat autoimmune or infectious diseases.

Country Status (16)

Country	Link
US (1)	US9566330B2 (en)
EP (1)	EP2687227B1 (en)
JP (2)	JP6181636B2 (en)
KR (1)	KR102008535B1 (en)
CN (1)	CN103717233B (en)
AU (1)	AU2012229902B2 (en)
BR (2)	BRPI1100857A2 (en)
CA (1)	CA2837348A1 (en)
CL (1)	CL2013002712A1 (en)
CO (1)	CO6831973A2 (en)
DK (1)	DK2687227T3 (en)
ES (1)	ES2699264T3 (en)
MX (1)	MX363050B (en)
PT (1)	PT2687227T (en)
RU (1)	RU2678317C2 (en)
WO (1)	WO2012122618A1 (en)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US10213504B2 (en)	2011-03-18	2019-02-26	Alexandre Eduardo Nowill	Immunogenic composition for modulating the immune system and methods to treat bacterial infections in a subject
GB201112091D0 (en)	2011-07-14	2011-08-31	Gt Biolog Ltd	Bacterial strains isolated from pigs
GB201117313D0 (en)	2011-10-07	2011-11-16	Gt Biolog Ltd	Bacterium for use in medicine
WO2013134179A2 (en)	2012-03-05	2013-09-12	Arctic Partners Oy	Methods and apparatuses for predicting risk of prostate cancer and prostate gland volume
GB201306536D0 (en)	2013-04-10	2013-05-22	Gt Biolog Ltd	Polypeptide and immune modulation
EP3010517A4 (en)	2013-06-21	2017-04-26	Ondek Pty Ltd	Immunotherapy composition and use thereof
EA201691952A1 (en)	2014-03-28	2017-05-31	Опкоу Дайагностикс, Ллк.	COMPOSITIONS AND METHODS RELEVANT TO DIAGNOSTIC PROSTATE CANCER
KR101631312B1 (en) *	2014-06-16	2016-06-20	연세대학교 산학협력단	Immunostimulatory Compositions Comprising Recombinant Giardia lamblia binding immunoglobulin protein
CN104546937B (en) *	2014-09-30	2019-02-01	深圳华大基因科技有限公司	Clostridium nexile is treating or preventing the application in rheumatoid arthritis or its related disease
JP6271093B1 (en)	2014-12-23	2018-01-31	フォーディーファーマリサーチリミテッド４ＤＰｈａｒｍａＲｅｓｅａｒｃｈＬｉｍｉｔｅｄ	Immunoregulation
ES2668934T3 (en)	2014-12-23	2018-05-23	4D Pharma Research Limited	Pirin polypeptide and immune modulation
TWI698639B (en)	2015-03-27	2020-07-11	美商Ｏｐｋｏ診斷法有限責任公司	Prostate antigen standards and uses thereof
NZ777234A (en)	2015-06-15	2022-02-25	4D Pharma Res Ltd	Compositions comprising bacterial strains
PE20180267A1 (en)	2015-06-15	2018-02-06	4D Pharma Res Ltd	COMPOSITIONS INCLUDING BACTERIAL STRAINS
PE20180243A1 (en)	2015-06-15	2018-01-31	4D Pharma Res Ltd	COMPOSITIONS INCLUDING BACTERIAL STRAINS
MA41010B1 (en)	2015-06-15	2020-01-31	4D Pharma Res Ltd	Compositions comprising bacterial strains
MA41060B1 (en)	2015-06-15	2019-11-29	4D Pharma Res Ltd	Compositions comprising bacterial strains
ES2662617T3 (en)	2015-11-20	2018-04-09	4D Pharma Research Limited	Compositions comprising bacterial strains
GB201520497D0 (en)	2015-11-20	2016-01-06	4D Pharma Res Ltd	Compositions comprising bacterial strains
GB201520631D0 (en)	2015-11-23	2016-01-06	4D Pharma Res Ltd	Compositions comprising bacterial strains
GB201520638D0 (en)	2015-11-23	2016-01-06	4D Pharma Res Ltd	Compositions comprising bacterial strains
GB201612191D0 (en)	2016-07-13	2016-08-24	4D Pharma Plc	Compositions comprising bacterial strains
CN114712405A (en)	2016-03-04	2022-07-08	4D制药有限公司	Compositions comprising bacterial strains
TW201821093A (en)	2016-07-13	2018-06-16	英商４Ｄ製藥有限公司	Compositions comprising bacterial strains
GB201621123D0 (en)	2016-12-12	2017-01-25	4D Pharma Plc	Compositions comprising bacterial strains
MX2019009689A (en) *	2017-02-13	2019-12-18	Eduardo Nowill Alexandre	Immunogenic composition for modulating the immune system and methods to treat bacterial infections in a subject.
RS61872B1 (en)	2017-05-22	2021-06-30	4D Pharma Res Ltd	Compositions comprising bacterial strains
JP6978514B2 (en)	2017-05-24	2021-12-08	フォーディーファーマリサーチリミテッド4D Pharma Research Limited	Composition containing bacterial strain
HUE052319T2 (en)	2017-06-14	2021-04-28	4D Pharma Res Ltd	Compositions comprising bacterial strains
AU2018285445B2 (en)	2017-06-14	2020-03-26	Cj Bioscience, Inc.	Compositions comprising bacterial strains
EP3600364B1 (en)	2017-06-14	2020-08-05	4D Pharma Research Limited	Compositions comprising a bacterial strain of the genus megasphaera and uses thereof
RU2699540C2 (en) *	2017-08-17	2019-09-06	Павел Павлович Несмиянов	Composition comprising probiotic bacteria or components thereof, and method for use thereof in treating immune skin diseases
JP7409612B2 (en) *	2018-02-02	2024-01-09	ユニバーシティオブワシントン	Compositions and methods for inducing tripatite motif-containing protein 16 (TRIM16) signaling
CN109010824A (en) *	2018-08-27	2018-12-18	广州汇高生物科技有限公司	A kind of special yolk immune globulin composite and its preparation
WO2020106158A1 (en) *	2018-11-20	2020-05-28	Acd Pharmaceuticals As	Serratia liquefaciens variant
EP3890759B1 (en) *	2018-12-04	2023-08-23	Sabiotec Spin-Off, S.L.	Immunostimulant for use against pathogens
CN110156885B (en) *	2019-05-23	2020-11-24	南京林业大学	Pathogenic-related mode molecular protein BxCDP1 of pine wood nematode and application thereof
WO2022040768A1 (en) *	2020-08-28	2022-03-03	Nowill Alexandre Eduardo	Compositions for uses in methods of treating coronavirus infections
CN113244273A (en) *	2021-03-16	2021-08-13	广州中科蓝华生物科技有限公司	Use of plasmodium in preparing anti-tumor preparation for combined radiotherapy
CN114606317B (en) *	2022-03-22	2022-12-02	中山大学附属第一医院	Flora marker for predicting lymph node metastasis of gastric cancer and application thereof
DE202023103094U1 (en)	2023-06-06	2023-06-30	Dasari Chandransh	A human cell regeneration system with an isolated regenerative gene of a planarian organism

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5595756A (en) *	1993-12-22	1997-01-21	Inex Pharmaceuticals Corporation	Liposomal compositions for enhanced retention of bioactive agents
CA2319309C (en) *	1998-02-05	2010-08-10	Smithkline Beecham Biologicals S.A.	Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination
US6432710B1 (en) *	1998-05-22	2002-08-13	Isolagen Technologies, Inc.	Compositions for regenerating tissue that has deteriorated, and methods for using such compositions
AT410635B (en) *	2000-10-18	2003-06-25	Cistem Biotechnologies Gmbh	VACCINE COMPOSITION
EP1617867B1 (en) *	2003-04-30	2011-10-26	Medi Service S.R.L.	Immunomodulating composition comprising a particulate fraction of bacterial mechanical lysates
CA2555253A1 (en) *	2004-02-06	2005-08-25	Yale University	Compositions of pamps and listeria monocytogenes and methods of use
PL1765391T3 (en) *	2004-06-07	2013-08-30	Qu Biologics Inc	Bacterial compositions for the treatment of cancer
JP2008544949A (en) *	2004-10-08	2008-12-11	ノバルティスバクシンズアンドダイアグノスティックス，インコーポレーテッド	Immunostimulatory and therapeutic compositions for pyogenic streptococci
EP2044224A4 (en) *	2006-07-27	2011-04-13	Ligocyte Pharmaceuticals Inc	Chimeric virus-like particles
EP2061800B1 (en) *	2006-08-15	2015-07-29	The Trustees of the University of Pennsylvania	Compositions comprising hmw-maa and fragments thereof, and methods of use thereof
EP1938835A1 (en) *	2006-12-29	2008-07-02	Pevion Biotech AG	Non-specific immunostimulating agents
WO2009073133A1 (en) *	2007-11-29	2009-06-11	Vaxinnate Corporation	Compositions of toll-like receptor agonists and papillomavirus antigens and uses thereof
US20110104293A1 (en) *	2008-07-01	2011-05-05	Bali Pulendran	Synergistic induction of humoral and cellular immunity by combinatorial activation of toll-like receptors
US10369204B2 (en) *	2008-10-02	2019-08-06	Dako Denmark A/S	Molecular vaccines for infectious disease
JP6046348B2 (en) *	2008-11-18	2016-12-14	タケダヴァクシーンズ，インコーポレイテッド	RSVFVLP and methods of making and using the same

2011
- 2011-03-18 BR BRPI1100857-1A patent/BRPI1100857A2/en not_active Application Discontinuation
2012
- 2012-03-19 KR KR1020137027403A patent/KR102008535B1/en active IP Right Grant
- 2012-03-19 CN CN201280024132.7A patent/CN103717233B/en active Active
- 2012-03-19 DK DK12757249.3T patent/DK2687227T3/en active
- 2012-03-19 WO PCT/BR2012/000072 patent/WO2012122618A1/en active Application Filing
- 2012-03-19 JP JP2014500207A patent/JP6181636B2/en active Active
- 2012-03-19 AU AU2012229902A patent/AU2012229902B2/en active Active
- 2012-03-19 BR BR112013023773A patent/BR112013023773B8/en active IP Right Grant
- 2012-03-19 EP EP12757249.3A patent/EP2687227B1/en active Active
- 2012-03-19 PT PT12757249T patent/PT2687227T/en unknown
- 2012-03-19 CA CA2837348A patent/CA2837348A1/en not_active Abandoned
- 2012-03-19 ES ES12757249T patent/ES2699264T3/en active Active
- 2012-03-19 MX MX2013010669A patent/MX363050B/en unknown
- 2012-03-19 RU RU2013143400A patent/RU2678317C2/en active
- 2012-03-19 US US14/006,077 patent/US9566330B2/en active Active
2013
- 2013-09-23 CL CL2013002712A patent/CL2013002712A1/en unknown
- 2013-10-17 CO CO13246905A patent/CO6831973A2/en unknown
2017
- 2017-02-24 JP JP2017033884A patent/JP2017132776A/en active Pending

Also Published As

Publication number	Publication date
CO6831973A2 (en)	2014-01-10
BR112013023773B1 (en)	2022-09-20
CA2837348A1 (en)	2012-09-20
RU2013143400A (en)	2015-04-27
PT2687227T (en)	2018-12-11
AU2012229902B2 (en)	2017-06-29
BR112013023773A2 (en)	2020-11-10
CN103717233B (en)	2020-05-26
ES2699264T3 (en)	2019-02-08
MX363050B (en)	2019-03-06
US9566330B2 (en)	2017-02-14
EP2687227B1 (en)	2018-08-22
WO2012122618A1 (en)	2012-09-20
KR102008535B1 (en)	2019-10-21
DK2687227T3 (en)	2018-12-10
EP2687227A1 (en)	2014-01-22
JP2014508783A (en)	2014-04-10
BR112013023773B8 (en)	2022-10-18
KR20140027162A (en)	2014-03-06
JP2017132776A (en)	2017-08-03
WO2012122618A8 (en)	2012-11-08
MX2013010669A (en)	2014-10-14
RU2678317C2 (en)	2019-01-28
CN103717233A (en)	2014-04-09
NZ616823A (en)	2016-08-26
BRPI1100857A2 (en)	2013-05-21
US20140037716A1 (en)	2014-02-06
JP6181636B2 (en)	2017-08-16
AU2012229902A1 (en)	2013-11-07
EP2687227A4 (en)	2014-10-01

Publication	Publication Date	Title
CL2013002712A1 (en)	2014-08-18	Immunogenic composition for modulating immune system comprising agents with patterns associated with bacteria, viruses, fungi and yeasts, protozoa, helminths and / or prions; use to treat autoimmune or infectious diseases.
CR20130620A (en)	2014-02-04	4-ARIL-N-FENIL-1,3,5-TRIAZIN-2-AMINAS CONTAINING A SULFOXIMINE GROUP
ECSP15011603A (en)	2015-12-31	FISH IMMERSION VACCINE SUBUNITIES
BR112015014482A2 (en)	2017-11-21	influenza vaccines and their uses
PE20181531A1 (en)	2018-09-26	SIMPLE HERPES VIRUS VACCINE
MD4589C1 (en)	2019-03-31	Pharmaceutical composition comprising sofosbuvir and uses thereof for treating hepatitis C virus
BR112014031891A2 (en)	2017-08-01	genetic targeting in plants using DNA viruses
CL2014000467A1 (en)	2014-09-05	Formulation comprising bacterial strain isolated from the genus burkholderia and derived pesticidal metabolites; method to obtain effective substance as a pesticide derived from the formulation indicated above.
BR112015007537A2 (en)	2017-07-04	plasma and peracetic acid activated water solution, and methods for preparing a solution and for deactivating or exterminating a spore, virus, microorganism, bacterium or fungus.
WO2013188848A3 (en)	2014-02-20	Antiviral compounds and methods of use
MX2015011529A (en)	2016-02-05	Influenza b virus reassortment.
WO2012024283A3 (en)	2012-05-18	Universal influenza a vaccines
MX2013003245A (en)	2013-05-22	Bvdv vaccine.
EA201400235A1 (en)	2014-09-30	VACCINES AGAINST FLU BASED ON H5
BR112014003003A2 (en)	2017-02-21	compounds, their uses and processes for treating or preventing viral infection
CL2015000037A1 (en)	2015-07-31	High efficiency method to purify particles similar to human papillomavirus.
WO2014008475A3 (en)	2014-04-10	Compositions and methods related to viral vaccines
MX350718B (en)	2017-09-14	Equine rhinitis vaccine.
MX360137B (en)	2018-10-24	H5 proteins of h5n1 influenza virus for use as a medicament.
CL2015003616A1 (en)	2016-09-23	Piscirickettsia salmonis strain deposited under the registration number dms 27338; vaccine that includes it; use to prevent infection by p. salmonis; and culture medium for p. salmonis
BR112015002458A2 (en)	2018-06-12	Packaged food concentrate, process for preparing a packaged food concentrate and use of packaged food concentrate.
CL2013002220A1 (en)	2014-02-14	Immunogenic composition comprising a canine influenza virus and a canine respiratory coronavirus; and its use to treat canine respiratory diseases.
ES2469948B2 (en)	2015-03-06	PROCEDURE TO DETECT IN PLANTS THE INFECTION BY SIMPLE CHAIN VIRUSES INFECTING GARLIC OYDV, LYSV, GCLV, SLV, IYSV and ALLEXIVIRUS.
WO2013026054A3 (en)	2013-06-27	Production of infectious rna viruses in yeast
Xu-Lei	2012	Reasoning Education: the Dimension of Constructing Civic Culture